250ml Medical Plastic Vaccine Vial Blue Translucent – Durable & Secure

Recent years have seen rapid growth in the global vaccine packaging market, driven by the surge in biologicals, expanding immunization programs, and the need for more sustainable, contamination-resistant materials. 250ml Medical Plastic Vaccine Vial Blue Translucent solutions, in particular, are rising in demand due to their optimum size, high clarity, and enhanced barrier properties. According to Pharma Packaging News, plastic vials have overtaken glass alternatives in high-volume, theft-prone, and cold chain applications.

Additionally, the COVID-19 pandemic underscored the importance of safe, efficient, and cost-effective packaging, propelling innovations like translucent medical-grade plastics and intelligent tracking features in packaging designs (Packaging Digest).

For manufacturers like CANGZHOU WEIKANG, adapting to these trends ensures products like the 250ml Medical Plastic Vaccine Vial Blue Translucent stay competitive and compliant with evolving regulatory requirements.

References: International Organization for Standardization (ISO)

1. What is the primary material for the 250ml Medical Plastic Vaccine Vial Blue Translucent?

It is manufactured from medical-grade polypropylene (PP) and polyethylene (PE), complying with global standards like USP 661.1 and ISO 8362.

2. What are the thickness and transparency specifications?

Uniform wall thickness of 1.6mm ± 0.2mm and high transparency (>85%), ensuring both physical strength and easy inspection.

3. Can it handle different sterilization methods?

Yes, the vial supports autoclaving, gamma, and ETO sterilization — with no deformation or color shift under 121°C, per IEC and USP standards.

4. Which international standards does it meet?

It complies with ISO 8362, EN ISO 11140, and the United States Pharmacopeia (USP) requirements for pharmaceutical packaging.

5. What sealing mechanisms are compatible?

The design is compatible with flip-off caps, aluminum seals, and screw caps for a wide compatibility range in packaging lines.

6. How is quality ensured during manufacturing?

Advanced injection-blow molding allows in-line inspection of wall thickness, air-tightness, and visual clarity, reducing defect rates to under 0.5%.

7. Are the vials suitable for cold chain or temperature-sensitive applications?

Absolutely, due to robust material formulation, the 250ml Medical Plastic Vaccine Vial Blue Translucent remains stable across pharmaceutical cold chain temperature ranges (2–8°C) and rapid thermal cycling conditions.

• Independently audited and ISO 9001 certified production environments
• High output capacity & quick lead times for global distribution
• Track record of regulatory compliance (FDA, EMEA, NMPA)
• Technical support and custom development available
• Competitive pricing and aftersales assurance

• Pharma Packaging News. "2024 Medical Plastic Packaging Market Analysis."
  https://www.pharmapackagingnews.com/medical-plastic-packaging-market/
• Elsevier. "Advances in Vaccine Packaging Material Solutions: An Industry Review."
  https://www.sciencedirect.com/science/article/pii/S0924013620304762
• Packaging Digest. "Pharmaceutical Vaccine Packaging: Trends and Forecasts for 2022–2027".
  https://www.packagingdigest.com/pharmaceutical-packaging/2022-pharma-packaging-trends
• World Health Organization (WHO), "Guidelines on the international packaging and shipping of vaccines".
  https://www.who.int/publications/i/item/9789241509871
• U.S. National Institutes of Health (NIH), "Sterile Pharmaceutical Packaging: Developments and Impact".
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013426/
• The International Organization for Standardization (ISO) Standards.
  https://www.iso.org/standard/75021.html
• USP 661.1 Packaging Standards.
  https://online.uspnf.com/

Harness the expertise and manufacturing excellence of CANGZHOU WEIKANG FOOD & PHARMACEUTICAL PACKAGE CO., LTD. for your next-generation 250ml Medical Plastic Vaccine Vial Blue Translucent solution!